The role of interleukin-4 and interleukin-13 in the non-immunologic aspects of asthma pathogenesis

Clinical Chemistry and Laboratory Medicine

Volumn 41, Issue 7, 2003, Pages 860-864

  Izuhara, Kenji ^a  

^a SAGA UNIVERSITY   (Japan)

Author keywords

Allergy; Bronchial asthma; Interleukin 13; Receptor; Squamous cell carcinoma antigen

Indexed keywords

CARBONATE DEHYDRATASE II; CARBOXYPEPTIDASE; COMPLEMENTARY DNA; CYSTEINE PROTEINASE; DIPEPTIDYL PEPTIDASE I; ENDOTHELIN RECEPTOR; INTERLEUKIN 13; INTERLEUKIN 4; SERINE PROTEINASE; SQUAMOUS CELL CARCINOMA ANTIGEN;

ANTIGEN EXPRESSION; ASTHMA; BRONCHUS BIOPSY; BRONCHUS MUCOSA; CELL CULTURE; CELL STIMULATION; CYTOKINE RELEASE; DNA LIBRARY; DNA MICROARRAY; EVIDENCE BASED MEDICINE; GENE CONTROL; GENETIC ANALYSIS; GENETIC ASSOCIATION; HUMAN; MOUSE; NONHUMAN; PATHOGENESIS; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN FUNCTION; RESPIRATORY TRACT INFLAMMATION; REVIEW; SIGNAL TRANSDUCTION; TH2 CELL;

ANIMALS; ASTHMA; GENE EXPRESSION REGULATION; HUMANS; INTERLEUKIN-13; INTERLEUKIN-13 RECEPTOR ALPHA1 SUBUNIT; INTERLEUKIN-4; MODELS, BIOLOGICAL; RECEPTORS, INTERLEUKIN; RECEPTORS, INTERLEUKIN-13; SIGNAL TRANSDUCTION;

BRONCHUS;

EID: 0041472595     PISSN: 14346621     EISSN: None     Source Type: Journal    
DOI: 10.1515/CCLM.2003.130     Document Type: Review

References (43)

1. Mao XQ, Sun DJ, Miyoshi A, Feng Z, Handzel ZT, Hopkin JM, et al. The link between helminthic infection and atopy. Parasitol Today 2000; 16:186-8.
2. Holgate ST. The epidemic of allergy and asthma. Nature 1999; 402:B2-4.
3. Akimoto T, Numata F, Tamura M, Takata Y, Higashida N, Takashi T, et al. Abrogation of bronchial eosinophilic inflammation and airway hyperreactivity in signal transducers and activators of transcription (STAT)6-deficient mice. J Exp Med 1998; 187:1537-42.
4. Cohn L, Homer RJ, MacLeod H, Mohrs M, Brombacher F, Bottomly K. Th2-induced airway mucus production is dependent on IL-4Rα, but not on eosinophils. J Immunol 1999; 162:6178-83.
5. Webb DC, McKenzie AN, Koskinen AM, Yang M, Mattes J, Foster PS. Integrated signals between IL-13, IL-4, and IL-5 regulate airway hyperreactivity. J Immunol 2000; 165:108-13.
6. Grünig G, Warnock M, Wakil AE, Venkayya R, Brombacher F, Rennick DM, et al. Requirement for IL-13 independently of IL-4 in experimental asthma. Science 1998; 282:2261-3.
7. Zhu Z, Homer RJ, Wang Z, Chen Q, Geba GP, Wang J, et al. Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production. J Clin Invest 1999; 103:779-88.
8. Wills-Karp M, Luyimbazi J, Xu X, Schofield B, Neben TY, Karp CL, et al. Interleukin-13: central mediator of allergic asthma. Science 1998; 282:2258-61.
9. Kuperman DA, Huang X, Koth LL, Chang GH, Dolganov GM, Zhu Z, et al. Direct effects of interleukin-13 on epithelial cells cause airway hyperreactivity and mucus overproduction in asthma. Nat Med 2002; 8:885-9.
10. Kotsimbos TC, Ernst P, Hamid QA. Interleukin-13 and interleukin-4 are coexpressed in atopic asthma. Proc Assoc Am Physicians 1996; 108:368-73.
11. Bodey KJ, Semper AE, Redington AE, Madden J, Teran LM, Holgate ST, et al. Cytokine profiles of BAL T cells and T-cell clones obtained from human asthmatic airways after local allergen challenge. Allergy 1999; 54:1083-93.
12. Izuhara K, Arima K, Yasunaga S. IL-4 and IL-13: their pathological roles in allergic diseases and their potential in developing new therapies. Current Drug Targets-Inflammation Allergy 2002; 1:263-9.
13. Barnes KC, Marsh DG. The genetics and complexity of allergy and asthma. Immunol Today 1998; 19:325-32.
14. Moffatt MF, Cookson WO. Genetics of asthma and inflammation: the status. Curr Opin Immunol 1999; 11:606-9.
15. Shirakawa T, Deichmann KA, Izuhara K, Mao I, Adra CN, Hopkin JM. Atopy and asthma: genetic variants of IL-4 and IL-13 signalling. Immunol Today 2000; 21:60-4.
16. Mitsuyasu H, Izuhara K, Mao X-Q, Gao P-S, Arinobu Y, Enomoto T, et al. IIe50Val variant of IL4Rα upregulates IgE synthesis and associates with atopic asthma. Nat Genet 1998; 19:119-20.
17. Mitsuyasu H, Yanagihara Y, Mao X-Q, Gao P-S, Arinobu Y, Ihara K, et al. Dominant effect of IIe50Val variant of the human interleukin-4 receptor α chain in IgE synthesis. J Immunol 1999; 162:1227-31.
18. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, Ohshima K, et al. Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 2000; 9:549-59.
19. Arima K, Umeshita-Suyama R, Sakata Y, Akaiwa M, Mao XQ, Enomoto T, et al. Upregulation of IL-13 concentration in vivo by the IL13 variant associated with bronchial asthma. J Allergy Clin Immunol 2002; 109:980-7.
20. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci USA 1996; 93:497-501.
21. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin 13 receptor α chain. J Biol Chem 1996; 271: 29265-70.
22. Orchansky PL, Ayres SD, Hilton DJ, Schrader JW. An interleukin (IL)-13 receptor lacking the cytoplasmic domain fails to transduce IL-13-induced signals and inhibits response to IL-4. J Biol Chem 1997; 272:22940-7.
23. Umeshita-Suyama R, Sugimoto R, Akaiwa M, Arima K, Yu B, Wada M, et al. Characterization of IL-4 and IL-13 signals dependent on the human IL-13 receptor α chain 1: redundancy of requirement of tyrosine residue for STAT3 activation. Int Immunol 2000; 12:1499-509.
24. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999; 17:701-38.
25. Caput D, Laurent P, Kaghad M, Lelias J-M, Lefort S, Vita N, et al. Cloning and characterization of a specific interleukin (IL)-13 binding protein structurally related to the IL-5 receptor a chain. J Biol Chem 1996; 271:16921-6.
26. Donaldson DD, Whitters MJ, Fitz LJ, Neben TY, Finnerty H, Henderson SL, et al. The murine IL-13 receptor α2: molecular cloning, characterization, and comparison with murine IL-13 receptor α1. J Immunol 1998; 161:2317-24.
27. Orchansky PL, Kwan R, Lee F, Schrader JW. Characterization of the cytoplasmic domain of interleukin-13 receptor-α. J Biol Chem 1999; 274:20818-25.
28. Izuhara K, Umeshita-Suyama R, Akaiwa M, Shirakawa T, Deichmann KA, Arima K, et al. Recent advances in understanding how interleukin-13 signals are involved in the pathogenesis of bronchial asthma. Arch Immunol Ther Exp 2000; 48:505-12.
29. Ogata H, Ford D, Kouttab N, King TC, Vita N, Minty A, et al. Regulation of interleukin-13 receptor constituents on mature human B lymphocytes. J Biol Chem 1998; 273:9864-71.
30. Akaiwa M, Yu B, Umeshita-Suyama R, Terada N, Suto H, Koga T, et al. Localization of human interleukin 13 receptor in non-haematopoietic cells. Cytokine 2001; 13:75-84.
31. Hoeck J, Woisetschlager M. STAT6 mediates eotaxin-1 expression in IL-4 or TNF-α-induced fibroblasts. J Immunol 2001; 166:4507-15.
32. Katz Y, Stav D, Barr J, Passwell JH. IL-13 results in differential regulation of the complement proteins C3 and factor B in tumour necrosis factor (TNF)-stimulated fibroblasts. Clin Exp Immunol 1995; 101:150-6.
33. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Jasmin C, Canonica GW, Azzarone B. IL-4 and IL-13 specifically increase adhesion molecule and inflammatory cytokine expression in human lung fibroblasts. Int Immunol 1998; 10:1421-33.
34. Moore PE, Church TL, Chism DD, Panettieri RA Jr, Shore SA. IL-13 and IL-4 cause eotaxin release in human airway smooth muscle cells: a role for ERK. Am J Physiol Lung Cell Mol Physiol 2002; 282:L847-53.
35. Hirst SJ, Hallsworth MP, Peng Q, Lee TH. Selective induction of eotaxin release by interleukin-13 or interleukin-4 in human airway smooth muscle cells is synergistic with interleukin-1β and is mediated by the interleukin-4 receptor α-chain. Am J Respir Crit Care Med 2002; 165:1161-71.
36. Yuyama N, Davies DE, Akaiwa M, Matsui K, Hamasaki Y, Suminami Y, et al. Analysis of novel disease-related genes in bronchial asthma. Cytokine 2002; 19:287-96.
37. Silverman GA, Bird PI, Carrell RW, Church FC, Coughlin PB, Gettins PG, et al. The serpins are an expanding superfamily of structurally similar but functionally diverse proteins. Evolution, mechanism of inhibition, novel functions, and a revised nomenclature. J Biol Chem 2001; 276:33293-6.
38. Cataltepe S, Gornstein ER, Schick C, Kamachi Y, Chatson K, Fries J, et al. Co-expression of the squamous cell carcinoma antigens 1 and 2 in normal adult human tissues and squamous cell carcinomas. J Histochem Cytochem 2000; 48:113-22.
39. Arlian LG and Platts-Mills TA. The biology of dust mites and the remediation of mite allergens in allergic disease. J Allergy Clin Immunol 2001; 107:S406-13.
40. Alexander J, Coombs GH, Mottram JC. Leishmania mexicana cysteine proteinase-deficient mutants have attenuated virulence for mice and potentiate a Th1 response. J Immunol 1998; 161:6794-801.
41. Pollock KG, McNeil KS, Mottram JC, Lyons RE, Brewer JM, Scott P, et al. The Leishmania mexicana cysteine protease, CPB2.8, induces potent Th2 responses. J Immunol 2003; 170:1746-53.
42. Kato H. Expression and function of squamous cell carcinoma antigen. Anticancer Res 1996; 16:2149-53.
43. Kawashima H, Nishimata S, Kashiwagi Y, Numabe H, Sasamoto M, Iwatsubo H, et al. Squamous cell carcinoma-related antigen in children with atopic dermatitis. Pediatr Int 2000; 42:448-50.